These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1720928)

  • 1. Immunochemistry of factor VIII:C inhibitor antibodies.
    Fulcher CA
    Am J Med; 1991 Nov; 91(5A):6S-8S. PubMed ID: 1720928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide.
    Ware J; MacDonald MJ; Lo M; de Graaf S; Fulcher CA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):703-16. PubMed ID: 1283342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization.
    Scandella D; Mattingly M; de Graaf S; Fulcher CA
    Blood; 1989 Oct; 74(5):1618-26. PubMed ID: 2477082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An introduction to factor VIII inhibitors: the detection and quantitation.
    Kessler CM
    Am J Med; 1991 Nov; 91(5A):1S-5S. PubMed ID: 1746589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates.
    Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R
    Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
    Yada K; Nogami K; Takeyama M; Ogiwara K; Wakabayashi H; Shima M
    J Thromb Haemost; 2015 Oct; 13(10):1843-53. PubMed ID: 26278069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments.
    Fulcher CA; de Graaf Mahoney S; Roberts JR; Kasper CK; Zimmerman TS
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7728-32. PubMed ID: 2415970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future approaches to factor VIII inhibitor therapy.
    Hoyer LW
    Am J Med; 1991 Nov; 91(5A):40S-44S. PubMed ID: 1746596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of factor VIII inhibitors.
    Shima M
    Int J Hematol; 2006 Feb; 83(2):109-18. PubMed ID: 16513528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of a major inhibitor epitope in factor VIII.
    Lubin IM; Healey JF; Scandella D; Runge MS; Lollar P
    J Biol Chem; 1994 Mar; 269(12):8639-41. PubMed ID: 7510693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative use of porcine factor VIII:C for immune tolerance induction.
    Hay CR
    Am J Med; 1991 Nov; 91(5A):27S-29S. PubMed ID: 1746593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sites.
    Kahle J; Orlowski A; Stichel D; Becker-Peters K; Kabiri A; Healey JF; Brettschneider K; Naumann A; Scherger AK; Lollar P; Schwabe D; Königs C
    Thromb Haemost; 2015 Feb; 113(2):396-405. PubMed ID: 25520269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of factor VIII antibody epitopes from haemophilia A patients using cellulose bound FVIII peptide libraries].
    Albert T; Lange S; Oldenburg J; Graw J; Schramm W; Hanfland P; Brackmann HH; Schwaab R
    Hamostaseologie; 2003 Feb; 23(1):13-7. PubMed ID: 12567194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-factor VIII antibodies: a 2005 update.
    Lavigne-Lissalde G; Schved JF; Granier C; Villard S
    Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII inhibitor antibodies with C2 domain specificity are less inhibitory to factor VIII complexed with von Willebrand factor.
    Suzuki T; Arai M; Amano K; Kagawa K; Fukutake K
    Thromb Haemost; 1996 Nov; 76(5):749-54. PubMed ID: 8950785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
    Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to factor VIII.
    Lacroix-Desmazes S; Misra N; Bayry J; Mohanty D; Kaveri SV; Kazatchkine MD
    Autoimmun Rev; 2002 Feb; 1(1-2):105-10. PubMed ID: 12849066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.